Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.
about
Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of AntiretroviralsEffect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarinModel-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients.ABCB1 genetic variants in leukemias: current insights into treatment outcomesInvestigation of the major cytochrome P450 1A2 genetic variant in a healthy Tibetan population in China.Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations.Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort studyClinical and pharmacogenomic implications of genetic variation in a Southern Ethiopian population.Miniature short hairpin RNA screens to characterize antiproliferative drugsGenetic diversity in black South Africans from SowetoAnalysis of CYP2C9*2, CYP2C9*3 and VKORC1 -1639 G>A polymorphisms in a population from South-Eastern Europe.A Global Health Diagnostic for Personalized Medicine in Resource-Constrained World Settings: A Simple PCR-RFLP Method for Genotyping CYP2B6 g.15582C>T and Science and Policy Relevance for Optimal Use of Antiretroviral Drug Efavirenz.ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients.Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descentPXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients.Pharmacogenomics of warfarin in populations of African descent.Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial.Genetic epidemiology of type 2 diabetes and cardiovascular diseases in Africa.Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.Africa: continent of genome contrasts with implications for biomedical research and health.Cytochrome P450 pharmacogenetics in African populations.Cytochrome P450 pharmacogenetics in African populations: implications for public health.Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes.Characterization of drug-metabolizing enzymes CYP2C9, CYP2C19 polymorphisms in Tunisian, Kuwaiti and Bahraini populations.Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.VKORC1-1639A allele influences warfarin maintenance dosage among Blacks receiving warfarin anticoagulation: a retrospective cohort study.Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients.Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population.Is there a role of pharmacogenomics in Africa.
P2860
Q28069383-658E4B63-3BB1-4D1E-8536-E2C7DEA64296Q28276514-9920F384-4F67-4AB3-86B4-B18F70E001CAQ30838395-F791A848-2408-48FB-A494-9B03C16623F4Q33707782-934260E4-0C16-416A-A8E5-CB8A7287091BQ33828034-AA156522-052C-42B2-A9AB-D79C43E086AFQ34491448-1B5005E8-E5BE-42C6-87DA-28F89FB63243Q34565428-BC1D3487-AD5B-46B7-BF0F-402D88F8018DQ34778035-68F15CC6-82BF-42C1-8643-AF01F58039ECQ34782184-66C7FA7F-88C3-434D-85FF-FB4B41182F45Q34995313-36449635-3FEA-4DA3-9892-34D56D5C56E9Q35370240-A9E9AEC5-E9F6-40E0-B2D3-AB9594E3E083Q35802412-86A60BA8-8981-4169-8079-A5318B26362CQ36370484-8F4A976B-5DD4-4BF3-9FB0-A1BCF1D9E45AQ36384257-C043B243-EA86-4228-9D38-5987FDC73843Q36468872-2AC73F0A-DDCA-48B4-A489-2C05906AB54AQ36629209-BF40312E-A001-49D2-BE6F-7CB3D8A7D0E0Q36973336-522216B4-2B74-4C7D-92AB-9962DC598121Q37342581-1E2D6203-5F56-4CD5-9AA3-035F756AA045Q37715233-AEB96329-1E1C-428A-B516-50D35F46C89AQ38031725-10F5FC57-42FB-41C9-AECB-AF0EE4A44262Q38099372-22CE2375-148F-4C7B-97EE-193E5E35FD72Q38192688-A651E328-B598-4C62-A117-A8F85C36C042Q38616806-042BA095-2DAF-4D60-86DB-40E9F16C51ECQ38643436-B0DBB4F8-D2CB-477C-88AB-8B501B240DA3Q38855703-989C7AE4-35DC-48D4-A9C1-AB868C803F6FQ44502093-BB10E531-0FA3-4FE8-ACF1-A9F829DB8C34Q47345423-E16CA694-E793-4EF8-BFEA-E3518BC382C2Q47895423-913E7D64-9A33-4AF8-A4F0-01E8AE406F32Q53833189-7B226DAF-AE09-4B26-AED0-10F1F056FE25Q54964575-BD388F41-B947-4464-9AFD-D10DF22E6F9D
P2860
Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Genetic variants in CYP (-1A2, ...... tion: a window into diversity.
@en
Genetic variants in CYP (-1A2, ...... tion: a window into diversity.
@nl
type
label
Genetic variants in CYP (-1A2, ...... tion: a window into diversity.
@en
Genetic variants in CYP (-1A2, ...... tion: a window into diversity.
@nl
prefLabel
Genetic variants in CYP (-1A2, ...... tion: a window into diversity.
@en
Genetic variants in CYP (-1A2, ...... tion: a window into diversity.
@nl
P2093
P2860
P50
P356
P1433
P1476
Genetic variants in CYP (-1A2, ...... tion: a window into diversity.
@en
P2093
Ingrid Du Plooy
Michèle Ramsay
Tracy McLellan
P2860
P304
P356
10.2217/PGS.11.106
P577
2011-12-01T00:00:00Z